Summary and take home messages: the foundation role of oral factor Xa inhibition for stroke prevention in atrial fibrillation and acute and extended management of venous thromboembolism.
Brigham and Women's Hospital, Boston (United States of America)
19
presentations
0
follower
4
more
presentations
in this session
Introduction and welcome: evidence and guideline-based validation for factor Xa-based management of thrombosis-related disorders in cardiovascular medicine.
Practical dimensions and optimal deployment of oral factor Xa inhibitors in patients with non-valvular atrial fibrillation: the role of key clinical factors.
Interactive case-based simulation focused on stroke prevention in atrial fibrillation: practical, real world management decisions using oral factor Xa inhibitors in patients with non-valvular atrial fibrillation.